Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
6.91
+0.01 (0.14%)
Mar 24, 2026, 4:00 PM EDT - Market closed

Journey Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
188871113493-
Market Cap Growth
74.63%-22.18%226.31%-63.39%--
Enterprise Value
187.8691.3198.524.9944.890
Last Close Price
6.913.915.761.925.38-
PE Ratio
--5.43-27.43-1.14-1.25-
PS Ratio
3.161.541.410.461.48-
PB Ratio
7.044.325.472.012.22-
P/TBV Ratio
6.153.985.161.981.51-
P/FCF Ratio
--9.4921.24-2.52-42.72-
P/OCF Ratio
--9.4921.24-2.52-42.72-
EV/Sales Ratio
3.161.631.240.340.71-
EV/EBITDA Ratio
--8.9955.27-1.08-1.39-
EV/EBIT Ratio
--6.68-47.51-0.91-1.29-
EV/FCF Ratio
--10.0018.80-1.85-20.58-
Debt / Equity Ratio
0.761.250.721.350.020.52
Debt / EBITDA Ratio
-20.50-2.478.27-0.99-0.030.68
Debt / FCF Ratio
-4.11-2.752.81-1.70-0.421.05
Net Debt / Equity Ratio
0.010.24-0.62-0.53-1.15-0.28
Net Debt / EBITDA Ratio
-0.29-0.47-7.130.391.49-0.36
Net Debt / FCF Ratio
-0.06-0.52-2.420.6722.09-0.55
Asset Turnover
0.720.710.870.730.851.04
Inventory Turnover
1.541.691.882.565.7012.91
Quick Ratio
1.080.871.020.901.401.15
Current Ratio
1.421.371.351.161.641.26
Return on Equity (ROE)
-37.69%-72.60%-20.64%-100.39%-168.12%81.00%
Return on Assets (ROA)
-6.74%-17.49%-2.42%-27.24%-48.56%13.52%
Return on Invested Capital (ROIC)
-21.50%-75.83%-16.10%-295.83%-326.03%40.76%
Return on Capital Employed (ROCE)
-12.14%-34.17%-5.66%-65.52%-100.36%42.66%
Earnings Yield
-4.62%-18.41%-3.65%-88.02%-80.30%-
FCF Yield
-2.10%-10.54%4.71%-39.68%-2.34%-
Buyback Yield / Dilution
-10.59%-9.57%-4.15%-0.42%-34.93%-
Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q